Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of Shares by Directors
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces the following Director purchases of, in aggregate, 364,589 ordinary shares in the Company:
| Name | Position | Number of Ordinary Shares Purchased
| Price per Ordinary Share | Resultant Shareholding | Percentage of Issued Share Capital |
| James Balmain
| Chief Executive Officer
| 7,300 | 54.0987p | 706,573 | 0.77% |
| Guy Mitchell
| Chief Financial Officer
| 9,200 | 54.0987p | 9,200 | 0.01% |
| Hugo Stephenson*
| Group Executive Director
| 100,000 | 54.0987p | 2,226,273 | 2.42% |
| Leslie-Ann Reed
| Non-Executive Director
| 57,100 | 52.5p | 57,100 | 0.06% |
| Andy Williams
| Non-Executive Director | 190,989 | 52.5p | 610,484 | 0.66% |
* Dr Stephenson's shareholding shown above excludes the 7,152,600 ordinary shares which are held by Blue Muse Investments Pty Ltd, as trustee of The Blue Muse Trust (a trust which is controlled by Hugo Stephenson's mother and of which close relatives including his children and friends of Hugo Stephenson are beneficiaries).
ENQUIRIES
| Induction James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer | Via Walbrook PR Ltd: induction@walbrookpr.com |
|
|
|
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies / Kailey Aliyar |
|
|
|
|
| Walbrook PR Ltd | |
| Paul McManus / Alice Woodings | Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 |
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve. Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | James Balmain |
| 2. | Reason for the notification | |
| a. | Position/status | Chief Executive Officer |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 54.0987 pence 7,300 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 11 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | Guy Mitchell |
| 2. | Reason for the notification | |
| a. | Position/status | Chief Financial Officer |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 54.0987 pence 9,200 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 11 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | Hugo Stephenson |
| 2. | Reason for the notification | |
| a. | Position/status | Group Executive Director |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 54.0987 pence 100,000 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 11 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | Leslie-Ann Reed |
| 2. | Reason for the notification | |
| a. | Position/status | Non-Executive Director |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 52.5 pence 57,100 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 11 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | Andy Williams |
| 2. | Reason for the notification | |
| a. | Position/status | Non-Executive Director |
| a. | Initial notification /Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a. | Name | Induction Healthcare Group plc |
| b. | LEI | 213800RY96GCZQW5TP19 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
| b. | Nature of the transaction | Purchase of Ordinary Shares |
| c. | Price(s) and volume(s) | 52.5 pence 190,989 Ordinary Shares |
| d. | Aggregated information ·Aggregated volume ·Price | N/A |
| e. | Date of the transaction | 11 April 2022 |
| f. | Place of the transaction | London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.